Skip to main content
. 2017 May 19;2017(5):CD011598. doi: 10.1002/14651858.CD011598.pub2

Campbell 2008.

Methods Randomised clinical trial, Australia
Participants 60 hospitalised adults with chronic kidney disease, at nutritional risk defined by trialists
Male:Female = 34:19 (after early exclusions)
Mean age = 69.9 years
Exclusion criteria: < 18 years, glomerular filtration rate (GFR) > 30 ml/min , previously seen by a dietitian for Stage IV CKD, communication or intellectual impairment inhibiting their ability to undertake the intervention and malnutrition from a cause other than CKD
Interventions Experimental group: A dietitian, experienced in renal nutrition, gave treatment over a 12‐week period and aimed to optimise nutritional status and attain evidence‐based dietary prescription. (n = 60)
Control group: Standard care(n = 31)
Outcomes QOL: Kidney Disease Quality of Life Short Form version 1.3, combining the Short Form‐36 (SF‐36), with a kidney disease‐specific module
Study dates Not stated
Notes We contacted the authors on 5th October 2015 by email: katrina.campbell@qub.ac.uk. We received no reply.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated sequence
Allocation concealment (selection bias) Low risk Concealed from recruiting officer
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Not blinded
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not described
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk 13 dropouts (> 5%). No use of intention‐to‐treat
Selective reporting (reporting bias) Unclear risk No protocol could be obtained and the trial did not report all‐cause mortality or serious adverse events.
For‐profit bias Low risk Royal Brisbane and Women’s Hospital Foundation seeding grant, Queensland University of Technology Postgraduate Research Award (PhD scholarship) and an Institute of Health and Biomedical Innovation Research Scholarship.
Other bias Low risk The trial appeared to be free of other components that could put it at risk of bias.